DK0415321T3 - Oligodendrocyt-cytotoksisk faktor - Google Patents

Oligodendrocyt-cytotoksisk faktor

Info

Publication number
DK0415321T3
DK0415321T3 DK90116388.1T DK90116388T DK0415321T3 DK 0415321 T3 DK0415321 T3 DK 0415321T3 DK 90116388 T DK90116388 T DK 90116388T DK 0415321 T3 DK0415321 T3 DK 0415321T3
Authority
DK
Denmark
Prior art keywords
oligodendrocyte
cytotoxic factor
factor
homologs
fragments
Prior art date
Application number
DK90116388.1T
Other languages
English (en)
Inventor
Avi Cohen
Michal Schwartz
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of DK0415321T3 publication Critical patent/DK0415321T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • General Engineering & Computer Science (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Toxicology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK90116388.1T 1989-08-28 1990-08-27 Oligodendrocyt-cytotoksisk faktor DK0415321T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL91459A IL91459A0 (en) 1989-08-28 1989-08-28 Oligodendrocyte inhibitory factor

Publications (1)

Publication Number Publication Date
DK0415321T3 true DK0415321T3 (da) 1995-12-27

Family

ID=11060333

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90116388.1T DK0415321T3 (da) 1989-08-28 1990-08-27 Oligodendrocyt-cytotoksisk faktor

Country Status (16)

Country Link
EP (1) EP0415321B1 (da)
JP (1) JPH0411896A (da)
KR (1) KR910004200A (da)
AT (1) ATE130008T1 (da)
CA (1) CA2024030A1 (da)
DE (1) DE69023433T2 (da)
DK (1) DK0415321T3 (da)
ES (1) ES2081884T3 (da)
FI (1) FI904229A7 (da)
GR (1) GR3018534T3 (da)
HU (1) HUT56117A (da)
IE (1) IE903108A1 (da)
IL (1) IL91459A0 (da)
NZ (1) NZ235059A (da)
PT (1) PT95123A (da)
ZA (1) ZA906853B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL97365A0 (en) * 1991-02-27 1992-05-25 Yeda Res & Dev Pharmaceutical compositions comprising a lymphokine
IE911318A1 (en) * 1990-04-23 1991-10-23 Yeda Res & Dev Use of a tumor necrosis factor for facilitating nerve¹regeneration
FI941451L (fi) * 1992-07-30 1994-05-11 Yeda Resarch And Debelopment C Entsymaattisesti valmistettu dimeerinen IL-2 ja sen valmistuksessa käytettävä, hermoista johdettu transglutaminaasi
US6267955B1 (en) 1995-09-15 2001-07-31 Yeda Research And Development Co. Ltd. Mononuclear phagocytes and their use to promote axonal regeneration
US5800812A (en) * 1995-09-15 1998-09-01 Yeda Research And Development Co. Ltd. Methods of use of mononuclear phagocytes to promote axonal regeneration

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL71440A0 (en) * 1984-04-04 1984-07-31 Univ Ramot Composition for nerve regeneration
IL87349A (en) * 1988-08-04 1994-06-24 Michal Schwartz Water-soluble factor that activates glial cells, its preparation and pharmaceutical compositions comprising it

Also Published As

Publication number Publication date
KR910004200A (ko) 1991-03-28
ZA906853B (en) 1991-06-26
DE69023433D1 (de) 1995-12-14
ES2081884T3 (es) 1996-03-16
FI904229A7 (fi) 1991-03-01
NZ235059A (en) 1992-09-25
FI904229A0 (fi) 1990-08-27
HU905507D0 (en) 1991-02-28
PT95123A (pt) 1991-05-22
JPH0411896A (ja) 1992-01-16
IE903108A1 (en) 1991-03-13
IL91459A0 (en) 1990-04-29
GR3018534T3 (en) 1996-03-31
EP0415321B1 (en) 1995-11-08
HUT56117A (en) 1991-07-29
EP0415321A1 (en) 1991-03-06
AU6137290A (en) 1991-02-28
ATE130008T1 (de) 1995-11-15
AU642897B2 (en) 1993-11-04
CA2024030A1 (en) 1991-03-01
DE69023433T2 (de) 1996-04-04

Similar Documents

Publication Publication Date Title
LTIP919A (en) Drugs and process for preparing thereof
CA2024767A1 (en) Interferon-gamma receptor fragment and its production
EP0328251A3 (en) 2-(2-hydroxy-3-phenoxypropylamino)ethylphenoxyacetamides and processes and intermediates for their preparation
GR3035682T3 (en) Non-glycosylated fgf-4 and compositions containing the same.
IL85627A (en) Pharmaceutical compositions for treatment of disorders of ischemic origin comprising metformin and its salts
EP0296573A3 (en) Novel nucleosides, their preparation and pharmaceutical novel nucleosides, their preparation and pharmaceutical compositions compositions
FR2669029B1 (fr) Nouveaux derives de la n-benzoyl proline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DK0415321T3 (da) Oligodendrocyt-cytotoksisk faktor
ATE111357T1 (de) Synergetische immunostimulierende zusammensetzung und ihre verwendung.
DK0443848T3 (da) Nyt antiulcermiddel
DE69128254D1 (de) Antihypertensive benzopyran-derivate
DE68927055D1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
MX164619B (es) Composicion para el tratamiento de lesiones cutaneas
MY130049A (en) Oligodendrocyte cytotoxic factor.
PT91415A (pt) Processo para a preparacao de novos derivados de furiltiazol
PT84405B (pt) Processo para a preparacao de composicoes farmaceuticas contendo 2-alcoxi-n-(1-azabiciclo {2.2.2} octil-3-benzamida-n-oxidos apropriadas para controlar a emese provocada por drogas anti-cancro
PT95566A (pt) Metodo para a utilizacao de derivados de 2-oxindole substituidos na posicao 3 como inibidores da biossintese de interleuquina-1
ATE80873T1 (de) Tetrahydropyridin-derivate.
BR9714184A (pt) Utilização de bonzoillquil-1,2,3,6-tetraidropiridinas
HUT54300A (en) Process for producing medicaments suitable for antiviral treatment
BR1100204A (pt) Composição farmacêutica para tratar esquizofrenia